Abdul Mannan: Pencil Cells in IDA – Why Most, but Not All Cases Show Them
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“‘I asked myself a question this week: why do pencil cells appear in most IDA cases but not all? The answer is more interesting than I expected.’
Most haematology trainees think pencil cells are equal to iron deficiency.
That is only half the story.
I looked at this properly this week — grounded literature search, real papers, no shortcuts.
Here is what the evidence actually says:
Pencil cells (elongated elliptocytes) appear in iron deficiency because low haemoglobin content changes how the red cell behaves under shear stress in the microcirculation. But the mechanism is genuinely debated.
Yip and Mohandas (Blood, 1983) found increased membrane stiffness from oxidative damage.
Reinhart (BJH, 1992) found the opposite — membrane elasticity is preserved and the cells actually pass more easily through narrow pores because of microcytosis.
Red cells live 120 days. Early iron deficiency means old, normally-shaped cells are still circulating. The film looks unremarkable. Biochemistry is already abnormal.
Severe hypochromia matters more than microcytosis alone. A patient with MCH of 18 pg shows pencil cells. One with MCH of 24 pg often does not.
Thalassaemia trait, anaemia of chronic disease, or partial treatment all suppress pencil cell formation even when IDA is present
Ford (Int J Lab Haematol, 2013) put it directly: the classic blood film appearances in iron deficiency are unreliable in practice.
So the teaching point is this.
Absence of pencil cells never excludes IDA. Their presence tells you something has been going on long enough, severely enough, for the circulating pool to turn over.
Stage. Severity. Duration. Concurrent conditions. That is why not all IDA films look the same.
What morphological finding has surprised you most in a confirmed IDA case?”
Other posts featuring Abdul Mannan on Hemostasis Today.
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026